Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection

Journal of NeuroVirology

Volumn 19, Issue 1, 2013, Pages 65-74

  Weber, Erica ^a,b   Morgan, Erin E ^b   Iudicello, Jennifer E ^b   Blackstone, Kaitlin ^a,b   Grant, Igor ^b   Ellis, Ronald J ^c   Letendre, Scott L ^d   Little, Susan ^d   Morris, Sheldon ^d   Smith, Davey M ^d   Moore, David J ^b   Woods, Steven Paul ^b  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

AIDS dementia complex; HIV; Neuropsychiatry; Substance abuse; Viral load

Indexed keywords

ALCOHOL; ANTIRETROVIRUS AGENT; METHAMPHETAMINE; VIRUS RNA;

ADULT; ANXIETY; ARTICLE; COGNITIVE DEFECT; DEMOGRAPHY; DEPRESSION; FEMALE; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION; LEARNING; MAJOR CLINICAL STUDY; MALE; MEMORY; MENTAL DISEASE; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; RISK FACTOR; SELF REPORT; SUBSTANCE ABUSE; VERBAL COMMUNICATION; VIRUS LOAD;

EID: 84873694141     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-012-0141-y     Document Type: Article

References (63)

1. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC
2. Ances BM, Sisti D, Vaida F, Liang CL, Leontiey O, Perthen JE; the HIV Neurobehavioral Research Program (HNRP) Group (2009) Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain. Neurology 73:702-708. doi: 10.1212/WNL.0b013e3181b59a97
3. Atkinson JH, Grant I (1994) Natural history of neuropsychiatric manifestations of HIV disease. Psychiatr Clin N Am 17:17-33
4. Atkinson JH, Higgins JE, Vigil O, Dubrow R, Remien RH, Steward WT, Grant I (2009) Psychiatric context of acute/early HIV infection. The NIMH Multisite Acute HIV Infection Study: IV. AIDS Behav 13:1061-1067. doi: 10.1007/s10461-009-9585-3
5. Barclay TR, Hinkin CH, Castellon SA, Mason KI, Reinhard MJ, Durvasula RS (2007) Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol 26:40-49. doi: 10.1037/0278-6133.26.1.40
6. Battery AIT (1944) Manual of directions and scoring. War Department, Adjutant General's Office, Washington, DC
7. Benedict RH, Schretlen D, Groninger L, Brandt J (1998) Hopkins Verbal Learning Test - Revised: normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychol 12:43-55. doi: 10.1076/clin.12.1.43. 1726
8. Benton AL, Hamsher K, Sivan AB (1994) Controlled Oral Word Association Test. In: Multilingual aphasia examination, 3rd edn. Iowa City, AJA Associates
9. + cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200:749-759. doi: 10.1084/jem.20040874
10. Brenner BG, Roger M, Routy JP, Moisi D, Ntemgwa M, Matte C; Quebec Primary HIV Infection Study Group (2007) High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis 195:951-959
11. Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte T D, Grant I; The HNRC Group (2004a) Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 26:307-319
12. Carey CL, Woods SP, Rippeth JD, Gonzalez R, Moore DJ, Marcotte TD; The HNRC Group (2004b) Initial validation of a screening battery for the detection of HIV-associated neurocognitive impairment. Clin Neuropsychol 18:234-248
13. Carey CL, Woods SP, Rippeth JD, Heaton RK, Grant I, The HNRC Group (2006) Prospective memory in HIV-1 infection. J Clin Exp Neuropsychol 28:536-548
14. Cattie JE, Doyle K, Weber E, Grant I, Woods SP, The HNRP Group (2012). Planning deficits in HIV-associated neurocognitive disorders: Component processes, cognitive correlates, and implications for everyday functioning. J Clin Exp Neuropsychol 34:906-918
15. Chana G, Everall IP, Crews L, Langford D, Adame A, Grant I; The HNRC Group (2006) Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users. Neurology 67:1486-1489
16. Ellis RJ, Badiee J, Vaida F, Letendre S, Heaton RK, Clifford D, Grant I; the CHARTER Group (2011) CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS 25:1747-1751
17. Gavin DR, Ross HE, Skinner HA (1989) Diagnostic Validity of the Drug Abuse Screening Test in the assessment of DSM-III drug disorders. Br J Addict 84:301-307. doi: 10.1111/j.1360-0443.1989.tb03463.x
18. Gavrilin MA, Mathes LE, Podell M (2002) Methamphetamine enhances cell-associated feline immunodeficiency virus replication in astrocytes. J Neurovirol 8:240-249. doi: 10.1080/13550280290049660
19. Gorman AA, Foley JM, Ettenhofer ML, Hinkin CH, van Gorp WG (2009) Functional consequences of HIV-associated neuropsychological impairment. Neuropsychol Rev 19:186-203. doi: 10.1007/s11065-009-9095-0
20. Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, Grant I; The HNRC Group (2004a) The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 10:317-331. doi: 10.1017/S1355617704102130
21. Heaton RK, Miller SW, Taylor MJ, Grant I (2004b) Revised comprehensive norms for an expanded Halstead-Reitan Battery: demographically adjusted neuropsychological norms for African American and Caucasian adults. Psychological Assessment Resources, Inc., Odessa, FL
22. Heaton RK, Clifford DB, Franklin DR Jr., Woods SP, Ake C, Vaida F; The CHARTER Group (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75:2087-2096
23. Heaton RK, Franklin DR Jr., Ellis RJ, McCutchan JA, Letendre SL, LeBlanc S; The HNRC Group (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17:3-16
24. Kamat R, Woods SP, Marcotte TD, Ellis RJ, Grant I (2012) Implications of apathy for everyday functioning outcomes in persons living with HIV infection. Arch Clin Neuropsychol 27(5):520-531
25. Kennedy CA, Skurnick J, Wan J, Quattrone G, Sheffet A, Quinones M, Louria D (1993) Psychological distress, drug and alcohol use as correlates of condom use in HIV-serodiscordant heterosexual couples. AIDS 7:1493-1499. doi: 10.1097/00002030-199311999-00014
26. Kerndt PR, Dubrow R, Aynalem G, Mayer KH, Beckwith C, Remein RH, Morin SF (2009) Strategies used in the detection of acute/early HIV infections. The NIMH Multisite Acute HIV Infection Study: I. AIDS Behav 13:1037-1045. doi: 10.1007/s10461-009-9580-8
27. Kløve H (1963) Grooved pegboard. Lafayette Instruments, Lafayette, IN
28. Lentz MR, Kim WK, Lee V, Bazner S, Halpern EF, Venna N, Gonzalez RG (2009) Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infection. Neurology 72:1465-1472. doi: 10.1212/WNL.0b013e3181a2e90a
29. Lentz MR, Kim WK, Kim H, Soulas C, Lee V, Venna N, Gonzalez RG (2011) Alterations in brain metabolism during the first year of HIV infection. J Neurovirol 17:220-229. doi: 10.1007/s13365-011-0030-9
30. Lyles RH, Munoz A, Yamashita TE, Bazmi H, Detels R, Rinaldo CR, Mellors JW for the Multicenter AIDS Cohort Study (2000) Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. J Infect Dis 181:872-880. doi: 10.1086/315339
31. Marcotte TD, Deutsch R, McCutchan JA, Moore DJ, Letendre S, Ellis RJ, Grant I, for the HIV Neurobehavioral Research Center (HNRC) Group (2003) Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion. Arch Neurol 60:1406-1412
32. McNair DM, Loor M, Droppleman LF (1981) Profile of mood states. Educational and Industrial Testing Service, San Diego, CA
33. Moore DJ, Letendre SL, Morris S, Umlauf A, Deutsch R, Smith DM, Grant I for the CHARTER Group (2011) Neurocognitive functioning in acute or early HIV infection. J Neurovirol 17:50-57. doi: 10.1007/s13365-010-0009-y
34. Moore DJ, Blackstone K, Woods SP, Ellis RJ, Atkinson JH, Heaton RK, Grant I; the HNRP Group and the TMARC Group (2012) Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence. AIDS Care: Psychological and Socio-medical Aspects of AIDS/HIV 24:1504-1513. doi: 10.1080/09540121.2012.672718
35. Norman MA, Moore DJ, Taylor MJ, Franklin D, Cysique L, Ake C, Heaton RK; the HNRC Group (2011) Demographically corrected norms for African Americans and Caucasians on the Hopkins Verbal Learning Test-Revised, Brief Visuospatial Memory Test-Revised, Stroop Color and Word Test, and Wisconsin Card Sorting Test 64 - Card Version. J Clin Exp Neuropsychol 33:793-804. doi: 10.1080/13803395.2011.559157
36. Nyenhuis DK, Yamamoto C, Luchetta T, Terrien A, Parmentier A (1999) Adult and geriatric normative data and validation of the profile of mood states. J Clin Psychol 55:79-86. doi: 10.1002/(SICI)1097-4679(199901)55:1<79::AID- JCLP8>3.0.CO;2-7
37. Pao D, Fisher M, Hue S, Dean G, Murphy G, Cane PA, Pillay D (2005). Transmission of HIV-1 during primary infection: relationship to sexual risk and sexually transmitted infections. AIDS 19:85-90. doi: 10.1097/00002030-200501030- 00010
38. Perry S, Jacobsberg L, Card CA, Ashman T, Frances A, Fishman B (1993) Severity of psychiatric symptoms after HIV testing. Am J Psychiatry 150:775-779
39. Pilcher CD, Tien HC, Eron JJ, Vernazza PL, Leu SY, Stewart PW, Cohen MS (2004). Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis 189:1785-1792. doi: 10.1086/386333
40. Plankey MW, Ostrow DG, Stall R, Cox C, Li X, Peck JA, Jacobson L (2007) The relationship between methamphetamine and popper use and risk of HIV seroconversion in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 45:85-92. doi: 10.1097/QAI.0b013e3180417c99
41. Raj A, Reed E, Santana MC, Walley AY, Welles SL, Horsburgh CR, Silverman JG (2009) The associations of binge alcohol use with HIV/STI risk and diagnosis among heterosexual African American men. Drug Alcohol Depend 101:101-106
42. Reinert DF, Allen JP (2007) Alcohol Use Disorders Identification Test: an update of research findings. Alcohol Clin Exp Res 31:185-199. doi: 10.1111/j.1530-0277.2006.00295.x
43. Rippeth, JD, Heaton RK, Carey CL, Marcotte TD, Moore DJ, Gonzalez R, Grant I.; and the HNRC Group (2004) Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc 10:1-14. doi: 10.1017/S1355617704101021
44. Rosenbloom MJ, Sullivan EV, Sassoon SA, O-Reilly A, Fama R, Kemper CA, Pfefferbaum A (2007) Alcoholism, HIV infection, and their comorbidity: factors affecting self-rated health-related quality of life. J Stud Alcohol Drugs 68:115-125
45. Rourke SB, Halman MH, Bassel C (1999) Neurocognitive complaints in HIV-infection and their relationship to depressive symptoms and neuropsychological functioning. J Clin Exp Neuropsychol 21:737-756
46. Saunders JB, Aasland OG, Barbor TF, De La Fuente JR, Grant M (1993) Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption - II. Addiction 88:791-804. doi: 10.1111/j.1360-0443.1993.tb02093.x
47. Schacker T, Collier AC, Hughes J, Shea T, Corey L (1996) Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 125:257-264
48. Schacker T, Hughes JP, Shea T, Coombs RW, Corey L (1998) Biological and virologic characteristics of primary HIV infection. Ann Intern Med 128:613-620
49. Scott JC, Woods SP, Matt GE, Meyer RA, Heaton RK, Atkinson JH, Grant I (2007) Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol Rev 17:275-297
50. Sevigny JJ, Albert SM, McDermott MP, Schifitto G, McArthur JC, Sacktor N,. Epstein LG (2007) An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. Arch Neurol 64:97-102
51. Skinner HA (1982) The Drug Abuse Screening Test. Addict Behav 7:363-371
52. Steele CM, Southwick L, Pagano R (1986) Drinking your troubles away: the role of activity in mediating alcohol's reduction of psychological stress. J Abnorm Psychol 95:173-180
53. Tambussi G, Gori A, Capiluppi B, Balotta C, Papagno L, Morandini B, Lazzarin A (2000) Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid. Clin Infect Dis 30:962-965. doi: 10.1086/313810
54. Tucker JS, Burnam MA, Sherbourne CD, Kung FK, Gifford AL (2003) Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med 114:573-580. doi: 10.1016/S0002-9343(03)00093-7
55. Wang X, Foryt P, Ochs R, Chung JH, Wu Y, Parrish T, Ragin AB (2011) Abnormalities in resting-state functional connectivity in early human immunodeficiency virus infection. Brain Connectivity 1:207-217. doi: 10.1089/brain.2011.0016
56. Weber E, Blackstone K, Iudicello JE, Morgan EE, Grant I, Moore DJ; The TMARC Group (2012) Neurocognitive deficits are associated with unemployment in chronic methamphetamine users. Drug Alcohol Depend 125:146-153
57. Weinhart LS, Carey MP (2000) Does alcohol lead to sexual risk behavior? Findings from event-level research. Ann Rev Sex Res 11:125-157
58. Wilkinson GS (1993) Wide Range Achievement Test Administration Manual, 3rd edn. Wide Range, Inc., Wilmington, DE
59. Woods SP, Rippeth JD, Conover E, Gongvatana A, Gonzalez R, Carey CL; The HNRC Group (2005b) Deficient strategic control of verbal encoding and retrieval in individuals with methamphetamine dependence. Neuropsychology 19:35-43
60. Woods SP, Scott JC, Sires DA, Grant I, Heaton RK, Tröster AI; the HNRC Group (2005a) Action (verb) fluency: test-retest reliability, normative standards, and construct validity. J Int Neuropsychol Soc 11:408-415. doi: 10.1017/S1355617705050460
61. World Health Organization (1998) Composite International Diagnostic Interview (CIDI, version 2.1). World Health Organization, Geneva
62. Yudko E, Lozhkina O, Fouts A (2007) A comprehensive review of the psychometric properties of the Drug Abuse Screening Test. J Subst Abus Treat 32:189-198. doi: 10.1016/j.jsat.2006.08.002
63. Zetola NM, Pilcher CD (2007) Diagnosis and management of acute HIV infection. Infect Dis Clin North Am 21:19-48. doi: 10.1016/j.idc.2007.01.008